Effect of angiotensin on noradrenaline-3H accumulation and synthesis in vivo.
D000804:Angiotensin II / Q000494:pharmacology* / Q000502:physiology; D000818:Animals; D001011:Aorta / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000096:biosynthesis; D003891:Desipramine / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000502:physiology; D009435:Synaptic Transmission; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D002395:Catecholamines; D014316:Tritium; D000804:Angiotensin II; D014443:Tyrosine; D010042:Ouabain; D003891:Desipramine; D009638:Norepinephrine